Navellier & Associates’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,477	Closed	-$406K	–	322
2016 Q2	$406K	Buy	3,477 +17	+0.5%	+$2.41K	0.06%	154
2016 Q1	$482K	Sell	3,460 -70	-2%	-$10.3K	0.06%	127
2015 Q4	$673K	Sell	3,530 -136	-4%	-$23.8K	0.07%	104
2015 Q3	$573K	Hold	3,666	–	–	0.06%	136
2015 Q2	$663K	Hold	3,666	–	–	0.06%	161
2015 Q1	$635K	Hold	3,666	–	–	0.06%	159
2014 Q4	$678K	Sell	3,666 -77	-2%	-$14.3K	0.03%	150
2014 Q3	$621K	Hold	3,743	–	–	0.03%	151
2014 Q2	$585K	Sell	3,743 -517	-12%	-$81.6K	0.03%	164
2014 Q1	$648K	Sell	4,260 -257	-6%	-$40.9K	0.03%	134
2013 Q4	$600K	Sell	4,517 -4,885	-52%	-$586K	0.03%	151
2013 Q3	$1.09M	Sell	9,402 -4,098	-30%	-$450K	0.03%	119
2013 Q2	$1.25M	Buy	+13,500	New	+$1.3M	0.06%	92